Solveig Hofvind

10.3k total citations · 3 hit papers
222 papers, 6.1k citations indexed

About

Solveig Hofvind is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Artificial Intelligence. According to data from OpenAlex, Solveig Hofvind has authored 222 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 178 papers in Oncology, 80 papers in Pulmonary and Respiratory Medicine and 77 papers in Artificial Intelligence. Recurrent topics in Solveig Hofvind's work include Global Cancer Incidence and Screening (166 papers), Digital Radiography and Breast Imaging (78 papers) and AI in cancer detection (77 papers). Solveig Hofvind is often cited by papers focused on Global Cancer Incidence and Screening (166 papers), Digital Radiography and Breast Imaging (78 papers) and AI in cancer detection (77 papers). Solveig Hofvind collaborates with scholars based in Norway, United States and Sweden. Solveig Hofvind's co-authors include Per Skaane, Sofie Sebuødegård, Randi Gullien, Andriy I. Bandos, Giske Ursin, Ellen B. Eben, Steinar Thoresen, David Gur, Kristina Lång and Solveig Roth Hoff and has published in prestigious journals such as PLoS ONE, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Solveig Hofvind

209 papers receiving 6.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comparison of Digital Mammography Alone and Digital Mammography Plus Tomosynthesis in a Population-based Screening Program

2013 720 citations Per Skaane, Andriy I. Bandos et al. Radiology profile →
Artificial intelligence-supported screen reading versus standard double reading in the Mammography Screening with Artificial Intelligence trial (MASAI): a clinical safety analysis of a randomised, controlled, non-inferiority, single-blinded, screening accuracy study

2023 237 citations Kristina Lång, Solveig Hofvind et al. profile →
Screening performance and characteristics of breast cancer detected in the Mammography Screening with Artificial Intelligence trial (MASAI): a randomised, controlled, parallel-group, non-inferiority, single-blinded, screening accuracy study

2025 35 citations Solveig Hofvind, Kristina Lång et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Solveig Hofvind Norway	41	3.4k	2.7k	2.7k	1.9k	1.2k	222	6.1k
Mireille J. M. Broeders Netherlands	40	3.9k 1.1×	1.6k 0.6×	1.6k 0.6×	1.5k 0.8×	1.2k 1.0×	192	6.0k
Sophia Zackrisson Sweden	30	3.0k 0.9×	2.3k 0.9×	1.9k 0.7×	2.3k 1.2×	2.2k 1.8×	164	6.9k
Ingvar Andersson Sweden	38	3.3k 1.0×	2.0k 0.7×	2.1k 0.8×	2.1k 1.1×	1.3k 1.1×	130	6.5k
Matthew Wallis United Kingdom	26	1.8k 0.5×	1.6k 0.6×	1.2k 0.5×	1.3k 0.7×	1.9k 1.6×	113	4.4k
Christoph I. Lee United States	38	1.5k 0.5×	1.3k 0.5×	1.3k 0.5×	2.2k 1.1×	566 0.5×	184	4.7k
Gary J. Whitman United States	40	1.4k 0.4×	1.1k 0.4×	925 0.3×	2.4k 1.3×	2.1k 1.8×	266	6.2k
Debra M. Ikeda United States	41	1.2k 0.3×	1.2k 0.5×	1.4k 0.5×	2.7k 1.4×	1.4k 1.1×	154	5.3k
Per Skaane Norway	37	2.0k 0.6×	2.7k 1.0×	2.4k 0.9×	1.7k 0.9×	962 0.8×	119	4.7k
Làszló Tabár Sweden	49	6.8k 2.0×	1.8k 0.7×	2.1k 0.8×	1.5k 0.8×	2.9k 2.5×	149	9.9k
Kathleen R. Brandt United States	33	1.5k 0.4×	1.6k 0.6×	1.2k 0.5×	889 0.5×	944 0.8×	74	3.3k

Countries citing papers authored by Solveig Hofvind

Since Specialization

Citations

This map shows the geographic impact of Solveig Hofvind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Solveig Hofvind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Solveig Hofvind more than expected).

Fields of papers citing papers by Solveig Hofvind

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Solveig Hofvind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Solveig Hofvind. The network helps show where Solveig Hofvind may publish in the future.

Co-authorship network of co-authors of Solveig Hofvind

This figure shows the co-authorship network connecting the top 25 collaborators of Solveig Hofvind. A scholar is included among the top collaborators of Solveig Hofvind based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Solveig Hofvind. Solveig Hofvind is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Thorat, Mangesh A., Marc Arbyn, David Baldwin, et al.. (2025). European Code Against Cancer, 5th edition – hormone replacement therapy, other common medical therapies and cancer. Molecular Oncology. 20(1). 117–133. 1 indexed citations

Eskild, Anne, et al.. (2024). The association of adolescent to midlife weight change with age at natural menopause: a population study of 263 586 women in Norway. American Journal of Epidemiology. 194(8). 2211–2218.

Moshina, Nataliia, et al.. (2024). Artificial Intelligence Algorithm for Subclinical Breast Cancer Detection. JAMA Network Open. 7(10). e2437402–e2437402. 11 indexed citations

Louro, Javier, Marta Román, Nataliia Moshina, et al.. (2023). Personalized Breast Cancer Screening: A Risk Prediction Model Based on Women Attending BreastScreen Norway. Cancers. 15(18). 4517–4517. 3 indexed citations

Larsen, Marthe, et al.. (2023). Norwegian radiologists’ expectations of artificial intelligence in mammographic screening – A cross-sectional survey. European Journal of Radiology. 167. 111061–111061. 2 indexed citations

Houssami, Nehmat, Solveig Hofvind, Kristy Robledo, et al.. (2021). Interval breast cancer rates for digital breast tomosynthesis versus digital mammography population screening: An individual participant data meta-analysis. EClinicalMedicine. 34. 100804–100804. 19 indexed citations

Hofvind, Solveig, Nataliia Moshina, Åsne Sørlien Holen, et al.. (2021). Interval and Subsequent Round Breast Cancer in a Randomized Controlled Trial Comparing Digital Breast Tomosynthesis and Digital Mammography Screening. Radiology. 300(1). 66–76. 26 indexed citations

Eskild, Anne, et al.. (2019). Temporal trends in age at menarche and age at menopause: a population study of 312 656 women in Norway. Human Reproduction. 35(2). 464–471. 54 indexed citations

Skaane, Per, Andriy I. Bandos, Loren T. Niklason, et al.. (2019). Digital Mammography versus Digital Mammography Plus Tomosynthesis in Breast Cancer Screening: The Oslo Tomosynthesis Screening Trial. Radiology. 291(1). 23–30. 116 indexed citations

10.

Bjelland, Elisabeth Krefting, Solveig Hofvind, Liisa Byberg, & Anne Eskild. (2018). The relation of age at menarche with age at natural menopause: a population study of 336 788 women in Norway. Human Reproduction. 33(6). 1149–1157. 43 indexed citations

11.

Hofvind, Solveig, et al.. (2018). Lower attendance rates in BreastScreen Norway among immigrants across all levels of socio-demographic factors: a population-based study. Journal of Public Health. 27(2). 229–240. 19 indexed citations

12.

Moen, Kåre, et al.. (2018). Mammographic screening attendance among immigrant and minority women: a systematic review and meta-analysis. Acta Radiologica. 59(11). 1285–1291. 32 indexed citations

13.

Falk, Ragnhild Sørum & Solveig Hofvind. (2016). Overdiagnosis in Mammographic Screening because of Competing Risk of Death. Cancer Epidemiology Biomarkers & Prevention. 25(5). 759–765. 7 indexed citations

14.

Román, Marta, Sidsel Graff‐Iversen, Elisabete Weiderpass, et al.. (2016). Postmenopausal Hormone Therapy and Breast Cancer Prognostic Characteristics: A Linkage between Nationwide Registries. Cancer Epidemiology Biomarkers & Prevention. 25(11). 1464–1473. 8 indexed citations

15.

Hofvind, Solveig, et al.. (2015). Mode of detection: an independent prognostic factor for women with breast cancer. Journal of Medical Screening. 23(2). 89–97. 30 indexed citations

16.

Hofvind, Solveig, Åsne Sørlien Holen, Turid Aas, et al.. (2015). Women treated with breast conserving surgery do better than those with mastectomy independent of detection mode, prognostic and predictive tumor characteristics. European Journal of Surgical Oncology. 41(10). 1417–1422. 84 indexed citations

17.

Paci, Euǵenio, et al.. (2014). European Breast Cancer Service Screening Outcomes: A First Balance Sheet of the Benefits and Harms. Cancer Epidemiology Biomarkers & Prevention. 23(7). 1159–1163. 70 indexed citations

18.

Ellingjord‐Dale, Merete, Tom Grotmol, Eunjung Lee, et al.. (2014). Breast Cancer Susceptibility Variants and Mammographic Density Phenotypes in Norwegian Postmenopausal Women. Cancer Epidemiology Biomarkers & Prevention. 23(9). 1752–1763. 6 indexed citations

19.

Hofvind, Solveig, et al.. (2012). Sensitivity and specificity of mammographic screening as practised in Vermont and Norway. British Journal of Radiology. 85(1020). e1226–e1232. 39 indexed citations

20.

Couto, Elisabeth, Samera Azeem Qureshi, Solveig Hofvind, et al.. (2011). Hormone therapy use and mammographic density in postmenopausal Norwegian women. Breast Cancer Research and Treatment. 132(1). 297–305. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact